ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together … Read More
We are hiring! Project Manager – Apply now!
ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together … Read More
Axelys and the sector-based industrial research clusters are joining forces to boost innovation in Quebec for the benefit of research centers, businesses and society.
Montréal, le 8 février 2023 – Axelys, la société de développement et de transfert des innovations issues de la recherche publique du Québec ainsi que les neuf (9) regroupements sectoriels de recherche industrielle (RSRI) composés de : CQDM, CQRDA, CRIAQ, CRIBIQ, CRITM, InnovÉÉ, MEDTEQ+, PRIMA Québec et Prompt, tous mandatés par le ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE), sont … Read More
Sweet Biopharma Day’s 3rd Edition | Québec, Canada Call for startup proposals, now open
Laval, Canada – (BUSINESSWIRE) – 8 February 2023 – We are pleased to announce that the 3rd edition of Sweet Biopharma Day will be held, in person, on April 12, 2023. This unique, by invitation-only event invites young Canadian biotechs to submit an application for a chance to present in front of key global biopharma companies, as well as leading … Read More
CQDM and Defence Therapeutics fund the development of a new cancer vaccine platform
Montreal, Quebec, February 2, 2023 – In celebration of World Cancer Day, CQDM is proud to announce the launch of a collaborative research project between Université de Montréal (UdeM), the Lady Davis Institute of the Jewish General Hospital and Defence Therapeutics, a Quebec-based biotechnology company specialized in the development of next-generation vaccines. The funding of this study, totalling $1,359,851, was … Read More
CQDM funds a collaborative research project between the RI-MUHC and Divocco AI to develop an artificial intelligence-driven technology that improves regional anesthesia
Montreal, Quebec, December 8, 2022 – CQDM is pleased to announce the funding of a research study carried out at the Research Institute of the McGill University Health Centre (RI-MUHC) in collaboration with Divocco AI, a Montreal-based company focusing on perioperative care improvement using artificial intelligence (AI)-derived medical devices. The funding, totalling $1,057,502, was made possible by a grant of … Read More
CQDM Funds a Project Aiming to Elucidate the Effets of Psilocybin on Neuronal Circuits in Order to Treat Depression
Montreal (Quebec), November 24, 2022 – CQDM is proud to announce the funding of a research project led by Rosemary Bagot, Associate Professor at the Department of Psychology at McGill University. The project will be funded in collaboration with McGill University, Cubed Biotech Inc. (“Cubed Biotech”), as well as McGill University’s Healthy Brains, Healthy Lives (HBHL) initiative and the Irving … Read More
ADRIQ 2022 Award – Warmest congratulations to Steven LaPlante of INRS and NMX Research and Solutions, winners of the Industrial Sectoral Research Group Award (RSRI) presented by CQDM!
Montréal, November 17, 2022 – During the 32nd ADRIQ 2022 Innovation Awards Gala, Steven LaPlante, a researcher at INRS – Armand-Frappier Santé Biotechnologie Research Centre, and NMX Research and Solutions, a Québec contract research firm, received one of the Industrial Sectoral Research Group Awards (RSRI). Presented by CQDM, this recognition aims to highlight the role of collaborative research as a lever … Read More
The Canadian Cancer Society, CQDM, the Cole Foundation and Oncopole grant close to $8.5 million to four researchers in Quebec to support pediatric cancer research
MONTREAL, November 2, 2022 ─ The Canadian Cancer Society (CCS), CQDM, the Cole Foundation and Oncopole – pôle cancer du FRQS announced, today, grants of $8,485,132 to finance four research projects in Quebec, as part of the Pediatric Cancer Research Initiative. This funding, which will take place over three years, is part of a unique partnership created to support pediatric cancer … Read More
JOB OFFER – DIRECTOR SCIENTIFIC AFFAIRS
ABOUT CQDM Since its creation, CQDM has raised nearly $190 million to fund the development of approximately 130 drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together world-leading … Read More